Skip to main content

IDEXX LABORATORIES INC /DE

For the period ended Dec 31, 2024. Filed Mar 28, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Dec 31, 2024 · Filed Mar 28, 2025

IDXX$676.04+0.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Appendix A

Reconciliation of Non-GAAP Financial Measures

We report our results in accordance with generally accepted accounting principles in the United States, or GAAP. We use certain non-GAAP financial measures in this Proxy Statement that exclude or adjust certain items to supplement our consolidated results presented in accordance with GAAP or as part of our executive compensation program. Our reconciliation of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with GAAP is included in this Appendix.

While we believe that these non-GAAP financial measures are useful in evaluating our business, this information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similarly titled measures reported by other companies.

After-Tax Return on Invested Capital, Excluding Cash and Investments (ROIC)

After-tax return on invested capital, excluding cash and investments (ROIC), is a non-GAAP financial measure that represents our after-tax income from operations, divided by our average invested capital, excluding cash and investments, using the beginning and ending balance sheet values. ROIC, after-tax income from operations and average invested capital, excluding cash and investments, are not measures of financial performance under GAAP and should be considered in addition to, and not as replacements of or superior measures to, return on assets, net income, total assets or other financial measures reported in accordance with GAAP. We believe that reporting ROIC provides useful information to investors for evaluating the efficiency and effectiveness of our use of capital.

IDEXX 2025 PROXY STATEMENTA-1

In this Proxy Statement, we report our ROIC for 2024. The reconciliation of this non-GAAP financial measure is as follows:

Numerator (amounts in thousands)For the Year Ended December 31, 2024
Income from operations (as reported)$1,128,337
After-tax income from operations(1)$902,672
Denominator (dollar amounts in thousands)As of December 31, 2024As of December 31, 2023
Total shareholders’ equity$1,595,313$1,484,530
Credit facility250,000250,000
Long-term debt, current and long-term617,573697,880
Deferred income tax assets(125,630)(107,364)
Deferred income tax liabilities11,3127,235
Total invested capital2,348,5682,332,281
Less cash and cash equivalents288,266453,932
Total invested capital, excluding cash and investments$2,060,302$1,878,349
Average invested capital, excluding cash and investments(2)$1,969,326
After-tax return on invested capital, excluding cash and investments (ROIC)45.8%
  1. After-tax income from operations represents income from operations reduced by our reported effective tax rate of 20.0% for the year ended December 31, 2024. Refer to Note 14 to our consolidated financial statements included in our 2024 Annual Report on Form 10-K for information on our effective tax rate.

  2. Average invested capital, excluding cash and investments, represents the average of the amount of total invested capital, excluding cash and investments, as of December 31, 2024 and December 31, 2023.

Comparable EPS Growth

Comparable EPS growth is a non-GAAP financial measure that represents the percentage change in earnings per share (diluted), as compared to the same period for the prior year, net of the impact of changes in foreign currency exchange rates and excluding the tax benefits of share-based compensation activity under ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, and non-recurring or unusual items (if any). Comparable EPS growth should be considered in addition to, and not as a replacement of or a superior measure to, earnings per share (diluted) growth reported in accordance with GAAP. We believe that reporting comparable EPS growth provides useful information to investors by facilitating better period-over-period comparisons of our fundamental earnings per share performance by excluding items that vary independent of performance and providing greater transparency regarding a key metric used by management.

A-2IDEXX 2025 PROXY STATEMENT

APPENDIX A + + +

In this Proxy Statement, we report comparable EPS growth for 2024, which excludes the impact of tax benefits of share-based compensation activity under ASU 2016-09, changes in foreign currency exchange rates and the accrual for an ongoing litigation matter. We estimate the net impact of changes in foreign currency exchange rates on EPS results by restating results to the average exchange rates or exchange rate assumptions for the comparative period, which includes adjusting for the estimated impacts of foreign currency hedging transactions and certain impacts on our effective tax rates.

The reconciliation of this non-GAAP financial measure is as follows:

For the Year Ended December 31, 2024($)For the Year Ended December 31, 2023($)Year-over-Year Growth
Earnings per share (diluted)10.6710.066%
Less: comparability adjustments
Share-based compensation activity0.240.16
Ongoing litigation matter(0.56)—
Change from currency(0.05)—
Comparable EPS Growth11.049.9012%

Amounts presented may not recalculate due to rounding.

Comparable Operating Margin Improvement

Comparable operating margin improvement is a non-GAAP financial measure that represents the percentage change in operating margin, as compared to the same period for the prior year, and excludes the impact of changes in foreign currency exchange rates and non-recurring or unusual items (if any). Comparable operating margin improvement should be considered in addition to, and not as a replacement of or a superior measure to, operating margin improvement reported in accordance with GAAP. We believe that reporting comparable operating margin improvement provides useful information to investors by facilitating better period-over-period comparisons of our fundamental operating margin performance by excluding items that vary independent of performance and providing greater transparency regarding a key metric used by management.

In this Proxy Statement, we report the comparable operating margin improvement for 2024, which excludes changes in foreign currency exchange rates in 2024 and the impact of an accrual for an ongoing litigation matter. We estimate the net impact of changes in foreign currency exchange rates on operating margin results by restating results to the average exchange rates or exchange rate assumptions for the comparative period, which includes adjusting for the estimated impacts of foreign currency hedging transactions and certain impacts on our effective tax rates.

IDEXX 2025 PROXY STATEMENTA-3

The reconciliation of this non-GAAP financial measure is as follows:

Dollar amounts in thousandsFor the Year Ended December 31, 2024For the Year Ended December 31, 2023Year-over-Year Change (basis points)
Income from operations$1,128,337$1,097,128
Operating margin29.0%30.0%-100 bps
Less: comparability adjustments
Change from currency(5,261)—
Ongoing litigation matter(61,500)—
Comparable income from operations$1,195,098$1,097,128
Comparable operating margin(1)30.6%30.0%60 bps
  1. Amounts presented may not recalculate to constant currency operating margin or constant currency margin improvement due to rounding.

Free Cash Flow and the Ratio of Free Cash Flow to Net Income

Free cash flow is a non-GAAP financial measure and means, with respect to a measurement period, the cash generated from operations during that period, reduced by our investments in property and equipment. The ratio of free cash flow to net income, or free cash flow conversion, is a non-GAAP financial measure that is defined as free cash flow, with respect to a measurement period, divided by net income for the same period. Free cash flow and the ratio of free cash flow to net income should each be considered in addition to, and not as a replacement of or a superior measure to, net cash provided by operating activities and the ratio of net cash provided by operating activities to net income, respectively. We believe that reporting free cash flow provides useful information to investors because free cash flow indicates the cash the operations of the business are generating after appropriate reinvestment for recurring investments in property and equipment that are required to operate the business. We believe that reporting the ratio of free cash flow to net income provides useful information to investors because it provides a useful way for investors to compare free cash flow over time.

In this Proxy Statement, we report our free cash flow and the ratio of free cash flow to net income for 2024. The reconciliation of these non-GAAP financial measures is as follows:

Dollar amounts in thousandsFor the Year Ended December 31, 2024
Net cash provided by operating activities$929,001
Investing cash flows attributable to purchases of property and equipment(120,922)
Free cash flow$808,079
Net income$887,867
Ratio of free cash flow to net income (expressed as a percentage)91%
A-4IDEXX 2025 PROXY STATEMENT

APPENDIX A + + +

Organic Revenue Growth

Organic revenue growth is a non-GAAP financial measure that represents the percentage change in revenue, as compared to the same period for the prior year, net of the impact of changes in foreign currency exchange rates, certain business acquisitions and divestitures. Organic revenue growth should be considered in addition to, and not as a replacement of or a superior measure to, revenue growth reported in accordance with GAAP. We believe that reporting organic revenue growth provides useful information to investors by facilitating easier comparisons of our revenue performance with prior and future periods and to the performance of our peers.

We exclude from organic revenue growth the effect of changes in foreign currency exchange rates because these changes are not under management’s control, are subject to volatility and can obscure underlying business trends. We calculate the impact on revenue resulting from changes in foreign currency exchange rates by applying the difference between weighted average exchange rates during 2024 and 2023 to foreign-currency-denominated revenues for 2023.

We also exclude from organic revenue growth the effect of certain business acquisitions and divestitures because the nature, size and number of these transactions can vary dramatically from period to period, and because they either require or generate cash as an inherent consequence of the transaction, and therefore can also obscure underlying business and operating trends. We consider acquisitions to be a business when all three elements of inputs, processes and outputs are present, consistent with ASU 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” In a business combination, if substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, we do not consider these assets to be a business. A typical acquisition that we do not consider a business is a customer list asset acquisition, which does not have all elements necessary to operate a business, such as employees or infrastructure. We believe that the efforts required to convert and retain these acquired customers are similar in nature to our existing customer base and therefore are included in organic revenue growth. The percentage change in revenue resulting from acquisitions represents revenues during the current year period, limited to the initial twelve months from the date of acquisition, that are directly attributable to business acquisitions.

In this Proxy Statement, we report our organic revenue growth and CAG Diagnostics recurring revenue organic growth in 2024. The reconciliation of these non-GAAP financial measures is as follows:

Dollar amounts in thousandsNet Revenue For the Year Ended December 31, 2024($)Net Revenue For the Year Ended December 31, 2023($)Dollar Change($)Percentage ChangeChange from CurrencyChange from AcquisitionsOrganic Revenue Growth(1)
Total Company3,897,5043,660,953236,5516.5%(0.3)%0.4%6.4%
CAG Diagnostics recurring revenue3,129,4922,935,425194,0676.6%(0.2)%—6.8%
  1. Amounts presented may not recalculate due to rounding.
IDEXX 2025 PROXY STATEMENTA-5

Achieved Results Under the 2024 Annual Performance-Based Cash Bonus Plan

For purposes of determining the financial performance factor under our 2024 annual performance-based cash bonus plan, results with respect to theoperating profit, earnings per share (diluted) and ROIC financial metrics were adjusted, pursuant to the terms of the 2024 annual performance-based cash bonus plan, to eliminate the effects of differences between foreign currency exchange rates during 2024, as compared to the rates assumed in setting target goals, and the effects of discrete items not anticipated at the beginning of the 2024 fiscal year and not reflected in the target goal, such as acquisitions and acquisition-related expenses and impacts from a discrete litigation expense accrual, as well as the tax effects of share-based compensation activity under ASU 2016-09, “Compensation — Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” The operating profit achieved result of $1,196.0 million under our 2024 annual performance-based cash bonus plan, compared to our GAAP operating profit of $1,128.3 million, reflects a $61.5 million adjustment related to an accrual for an ongoing litigation matter, an adjustment of $6.9 million to eliminate foreign currency exchange rate effects and an aggregate adjustment of $(0.7) million for other discrete items. The earnings per shared (diluted) achieved result of $11.16 under our 2024 annual performance-based cash bonus plan, compared to GAAP earnings per share (diluted) of $10.67, reflects a $0.56 per share adjustment related to an accrual for an ongoing litigation matter, a $0.07 per share adjustment to eliminate foreign currency exchange rate effects, a $(0.14) per share adjustment for the tax effects of share-based compensation activity and an aggregate $(0.01) adjustment for other discrete items. The ROIC achieved result of 48.9% under our 2024 annual performance-based cash bonus plan, compared to 45.8% as disclosed earlier in Appendix A, reflects a 250 basis point adjustment related to an accrual for an ongoing litigation matter, a 30 basis point adjustment to eliminate foreign currency exchange rate effects and an aggregate 30 basis point adjustment for other discrete items.

A-6IDEXX 2025 PROXY STATEMENT
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.